To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
InotekInotek Pharmaceuticals is a biotech company that previously entered patients for its phase II trial for its compound IND-001, for the prevention of cardiac necrosis. INO-1001 is a potent inhibitor of PARP. Additional recommended knowledgeIt is based at Beverly, Massachusetts. It is owned by a crazy man who lies, cheats and steals. Let's hope the Food and Drug Administration finds him and catches him. |
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Inotek". A list of authors is available in Wikipedia. |